Scan to download
BTC $74,688.03 -0.50%
ETH $2,321.89 -1.55%
BNB $628.00 +0.53%
XRP $1.43 +1.44%
SOL $87.67 +2.63%
TRX $0.3255 -0.06%
DOGE $0.0968 +0.38%
ADA $0.2530 +1.36%
BCH $447.94 +1.02%
LINK $9.36 +0.49%
HYPE $43.52 -4.72%
AAVE $112.11 +5.30%
SUI $0.9778 +0.79%
XLM $0.1648 +3.00%
ZEC $332.17 -3.01%
BTC $74,688.03 -0.50%
ETH $2,321.89 -1.55%
BNB $628.00 +0.53%
XRP $1.43 +1.44%
SOL $87.67 +2.63%
TRX $0.3255 -0.06%
DOGE $0.0968 +0.38%
ADA $0.2530 +1.36%
BCH $447.94 +1.02%
LINK $9.36 +0.49%
HYPE $43.52 -4.72%
AAVE $112.11 +5.30%
SUI $0.9778 +0.79%
XLM $0.1648 +3.00%
ZEC $332.17 -3.01%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01
Collection

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.